Together, ROS, LOX-1, and RAS form a vicious cycle that induces fibroblast proliferation, endothelial dysfunction, and inflammation, leading to dyslipidemia and an increased risk of atherosclerosis and hypertension in MetS. The gene discussed is OLR1; the disease is metabolic syndrome.